Clevidipine Bolus Administration in the Treatment of Hypertensive Patients Undergoing Cardiac Surgery (SPRINT)

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Hypertension
Interventions
DRUG

clevidipine

Clevidipine (0.5mg/mL in 20% lipid emulsion) was administered as an IV bolus (\<5 sec) by rapid injection for Bolus 1 and for Bolus 2, if second bolus dose was administered, directly into a peripheral venous catheter followed by a normal saline flush (10mL).

Trial Locations (2)

19104

Hospital of the University of Pennsylvania, Philadelphia

02114

Massachusetts General Hospital, Harvard Medical School, Boston

Sponsors
All Listed Sponsors
lead

The Medicines Company

INDUSTRY